ALDH2 and non-small cell lung carcinoma: Indeed, the efficacy of PTX was significantly increased in the NSCLC/PTX cells after the knockdown of ALDH2, whereas the efficacy of PTX was significantly decreased in NSCLC cells overexpressing ALDH2 (Fig. 2A-B).